المؤلفون: McMahon, EM, Corcoran, P, Keeley, H, Clarke, M, Coughlan, H, Wasserman, D, Hoven, CW, Carli, V, Sarchiapone, M, Healy, C, Cannon, M

المصدر: Psychological medicine. 51(7):1220-1228

مصطلحات موضوعية: Medicin och hälsovetenskap

الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:146840552Test

المؤلفون: Staines, L, Healy, C, Corcoran, P, Keeley, H, Coughlan, H, McMahon, E, Cotter, P, Cotter, D, Kelleher, I, Wasserman, C, Brunner, R, Kaess, M, Sarchiapone, M, Hoven, CW, Carli, V, Wasserman, D, Cannon, M

المصدر: BMC public health. 23(1):553

مصطلحات موضوعية: Medicin och hälsovetenskap

الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:152321527Test

المؤلفون: Staines, L, Healy, C, Corcoran, P, Keeley, H, Coughlan, H, McMahon, E, Cotter, P, Cotter, D, Kelleher, I, Wasserman, C, Brunner, R, Kaess, M, Sarchiapone, M, Hoven, CW, Carli, V, Wasserman, D, Cannon, M

المصدر: BMC public health. 23(1):219

مصطلحات موضوعية: Medicin och hälsovetenskap

الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:151828887Test

المؤلفون: Abat S., Abd Rahman R., Abdul Cader R., Abdul Hafidz M. I., Abdul Wahab M. Z., Abdullah N. K., Abdul-Samad T., Abe M., Abraham N., Acheampong S., Achiri P., Acosta J. A., Adeleke A., Adell V., Adewuyi-Dalton R., Adnan N., Africano A., Agharazii M., Aguilar F., Aguilera A., Ahmad M., Ahmad M. K., Ahmad N. A., Ahmad N. H., Ahmad N. I., Ahmad Miswan N., Ahmad Rosdi H., Ahmed I., Ahmed S., Aiello J., Aitken A., AitSadi R., Aker S., Akimoto S., Akinfolarin A., Akram S., Alberici F., Albert C., Aldrich L., Alegata M., Alexander L., Alfaress S., Alhadj Ali M., Ali A., Alicic R., Aliu A., Almaraz R., Almasarwah R., Almeida J., Aloisi A., Al-Rabadi L., Alscher D., Alvarez P., Al-Zeer B., Amat M., Ambrose C., Ammar H., An Y., Andriaccio L., Ansu K., Apostolidi A., Arai N., Araki H., Araki S., Arbi A., Arechiga O., Armstrong S., Arnold T., Aronoff S., Arriaga W., Arroyo J., Arteaga D., Asahara S., Asai A., Asai N., Asano S., Asawa M., Asmee M. F., Aucella F., Augustin M., Avery A., Awad A., Awang I. Y., Awazawa M., Axler A., Ayub W., Azhari Z., Baccaro R., Badin C., Bagwell B., Bahlmann-Kroll E., Bahtar A. Z., Baigent C., Bains D., Bajaj H., Baker R., Baldini E., Banas B., Banerjee D., Banno S., Bansal S., Barberi S., Barnes S., Barnini C., Barot C., Barrett K., Barrios R., Bartolomei Mecatti B., Barton I., Barton J., Basily W., Bavanandan S., Baxter A., Becker L., Beddhu S., Beige J., Beigh S., Bell S., Benck U., Beneat A., Bennett A., Bennett D., Benyon S., Berdeprado J., Bergler T., Bergner A., Berry M., Bevilacqua M., Bhairoo J., Bhandari S., Bhandary N., Bhatt A., Bhattarai M., Bhavsar M., Bian W., Bianchini F., Bianco S., Bilous R., Bilton J., Bilucaglia D., Bird C., Birudaraju D., Biscoveanu M., Blake C., Bleakley N., Bocchicchia K., Bodine S., Bodington R., Boedecker S., Bolduc M., Bolton S., Bond C., Boreky F., Boren K., Bouchi R., Bough L., Bovan D., Bowler C., Bowman L., Brar N., Braun C., Breach A., Breitenfeldt M., Brenner S., Brettschneider B., Brewer A., Brewer G., Brindle V., Brioni E., Brown C., Brown H., Brown L., Brown R., Brown S., Browne D., Bruce K., Brueckmann M., Brunskill N., Bryant M., Brzoska M., Bu Y., Buckman C., Budoff M., Bullen M., Burke A., Burnette S., Burston C., Busch M., Bushnell J., Butler S., Buttner C., Byrne C., Caamano A., Cadorna J., Cafiero C., Cagle M., Cai J., Calabrese K., Calvi C., Camilleri B., Camp S., Campbell D., Campbell R., Cao H., Capelli I., Caple M., Caplin B., Cardone A., Carle J., Carnall V., Caroppo M., Carr S., Carraro G., Carson M., Casares P., Castillo C., Castro C., Caudill B., Cejka V., Ceseri M., Cham L., Chamberlain A., Chambers J., Chan C. B. T., Chan J. Y. M., Chan Y. C., Chang E., Chant T., Chavagnon T., Chellamuthu P., Chen F., Chen J., Chen P., Chen T. M., Chen Y., Cheng C., Cheng H., Cheng M. C., Cherney D., Cheung A. K., Ching C. H., Chitalia N., Choksi R., Chukwu C., Chung K., Cianciolo G., Cipressa L., Clark S., Clarke H., Clarke R., Clarke S., Cleveland B., Cole E., Coles H., Condurache L., Connor A., Convery K., Cooper A., Cooper N., Cooper Z., Cooperman L., Cosgrove L., Coutts P., Cowley A., Craik R., Cui G., Cummins T., Dahl N., Dai H., Dajani L., D'Amelio A., Damian E., Damianik K., Danel L., Daniels C., Daniels T., Darbeau S., Darius H., Dasgupta T., Davies J., Davies L., Davis A., Davis J., Davis L., Dayanandan R., Dayi S., Dayrell R., De Nicola L., Debnath S., Deeb W., Degenhardt S., DeGoursey K., Delaney M., Deo R., DeRaad R., Derebail V., Dev D., Devaux M., Dhall P., Dhillon G., Dienes J., Dobre M., Doctolero E., Dodds V., Domingo D., Donaldson D., Donaldson P., Donhauser C., Donley V., Dorestin S., Dorey S., Doulton T., Draganova D., Draxlbauer K., Driver F., Du H., Dube F., Duck T., Dugal T., Dugas J., Dukka H., Dumann H., Durham W., Dursch M., Dykas R., Easow R., Eckrich E., Eden G., Edmerson E., Edwards H., Ee L. W., Eguchi J., Ehrl Y., Eichstadt K., Eid W., Eilerman B., Ejima Y., Eldon H., Ellam T., Elliott L., Ellison R., Emberson J., Epp R., Er A., Espino-Obrero M., Estcourt S., Estienne L., Evans G., Evans J., Evans S., Fabbri G., Fajardo-Moser M., Falcone C., Fani F., Faria-Shayler P., Farnia F., Farrugia D., Fechter M., Fellowes D., Feng F., Fernandez J., Ferraro P., Field A., Fikry S., Finch J., Finn H., Fioretto P., Fish R., Fleischer A., Fleming-Brown D., Fletcher L., Flora R., Foellinger C., Foligno N., Forest S., Forghani Z., Forsyth K., Fottrell-Gould D., Fox P., Frankel A., Fraser D., Frazier R., Frederick K., Freking N., French H., Froment A., Fuchs B., Fuessl L., Fujii H., Fujimoto A., Fujita A., Fujita K., Fujita Y., Fukagawa M., Fukao Y., Fukasawa A., Fuller T., Funayama T., Fung E., Furukawa M., Furukawa Y., Furusho M., Gabel S., Gaidu J., Gaiser S., Gallo K., Galloway C., Gambaro G., Gan C. C., Gangemi C., Gao M., Garcia K., Garcia M., Garofalo C., Garrity M., Garza A., Gasko S., Gavrila M., Gebeyehu B., Geddes A., Gentile G., George A., George J., Gesualdo L., Ghalli F., Ghanem A., Ghate T., Ghavampour S., Ghazi A., Gherman A., Giebeln-Hudnell U., Gill B., Gillham S., Girakossyan I., Girndt M., Giuffrida A., Glenwright M., Glider T., Gloria R., Glowski D., Goh B. L., Goh C. B., Gohda T., Goldenberg R., Goldfaden R., Goldsmith C., Golson B., Gonce V., Gong Q., Goodenough B., Goodwin N., Goonasekera M., Gordon A., Gordon J., Gore A., Goto H., Goto S., Gowen D., Grace A., Graham J., Grandaliano G., Gray M., Green J. B., Greene T., Greenwood G., Grewal B., Grifa R., Griffin D., Griffin S., Grimmer P., Grobovaite E., Grotjahn S., Guerini A., Guest C., Gunda S., Guo B., Guo Q., Haack S., Haase M., Haaser K., Habuki K., Hadley A., Hagan S., Hagge S., Haller H., Ham S., Hamal S., Hamamoto Y., Hamano N., Hamm M., Hanburry A., Haneda M., Hanf C., Hanif W., Hansen J., Hanson L., Hantel S., Haraguchi T., Harding E., Harding T., Hardy C., Hartner C., Harun Z., Harvill L., Hasan A., Hase H., Hasegawa F., Hasegawa T., Hashimoto A., Hashimoto C., Hashimoto M., Hashimoto S., Haskett S., Hauske S. J., Hawfield A., Hayami T., Hayashi M., Hayashi S., Haynes R., Hazara A., Healy C., Hecktman J., Heine G., Henderson H., Henschel R., Hepditch A., Herfurth K., Hernandez G., Hernandez Pena A., Hernandez-Cassis C., Herrington W. G., Herzog C., Hewins S., Hewitt D., Hichkad L., Higashi S., Higuchi C., Hill C., Hill L., Hill M., Himeno T., Hing A., Hirakawa Y., Hirata K., Hirota Y., Hisatake T., Hitchcock S., Hodakowski A., Hodge W., Hogan R., Hohenstatt U., Hohenstein B., Hooi L., Hope S., Hopley M., Horikawa S., Hosein D., Hosooka T., Hou L., Hou W., Howie L., Howson A., Hozak M., Htet Z., Hu X., Hu Y., Huang J., Huda N., Hudig L., Hudson A., Hugo C., Hull R., Hume L., Hundei W., Hunt N., Hunter A., Hurley S., Hurst A., Hutchinson C., Hyo T., Ibrahim F. H., Ibrahim S., Ihana N., Ikeda T., Imai A., Imamine R., Inamori A., Inazawa H., Ingell J., Inomata K., Inukai Y., Ioka M., Irtiza-Ali A., Isakova T., Isari W., Iselt M., Ishiguro A., Ishihara K., Ishikawa T., Ishimoto T., Ishizuka K., Ismail R., Itano S., Ito H., Ito K., Ito M., Ito Y., Iwagaitsu S., Iwaita Y., Iwakura T., Iwamoto M., Iwasa M., Iwasaki H., Iwasaki S., Izumi K., Izumi T., Jaafar S. M., Jackson C., Jackson Y., Jafari G., Jahangiriesmaili M., Jain N., Jansson K., Jasim H., Jeffers L., Jenkins A., Jesky M., Jesus-Silva J., Jeyarajah D., Jiang Y., Jiao X., Jimenez G., Jin B., Jin Q., Jochims J., Johns B., Johnson C., Johnson T., Jolly S., Jones L., Jones S., Jones T., Jones V., Joseph M., Joshi S., Judge P., Junejo N., Junus S., Kachele M., Kadowaki T., Kadoya H., Kaga H., Kai H., Kajio H., Kaluza-Schilling W., Kamaruzaman L., Kamarzarian A., Kamimura Y., Kamiya H., Kamundi C., Kan T., Kanaguchi Y., Kanazawa A., Kanda E., Kanegae S., Kaneko K., Kang H. Y., Kano T., Karim M., Karounos D., Karsan W., Kasagi R., Kashihara N., Katagiri H., Katanosaka A., Katayama A., Katayama M., Katiman E., Kato K., Kato M., Kato N., Kato S., Kato T., Kato Y., Katsuda Y., Katsuno T., Kaufeld J., Kavak Y., Kawai I., Kawai M., Kawase A., Kawashima S., Kazory A., Kearney J., Keith B., Kellett J., Kelley S., Kershaw M., Ketteler M., Khai Q., Khairullah Q., Khandwala H., Khoo K. K. L., Khwaja A., Kidokoro K., Kielstein J., Kihara M., Kimber C., Kimura S., Kinashi H., Kingston H., Kinomura M., Kinsella-Perks E., Kitagawa M., Kitajima M., Kitamura S., Kiyosue A., Kiyota M., Klauser F., Klausmann G., Kmietschak W., Knapp K., Knight C., Knoppe A., Knott C., Kobayashi M., Kobayashi R., Kobayashi T., Koch M., Kodama S., Kodani N., Kogure E., Koizumi M., Kojima H., Kojo T., Kolhe N., Komaba H., Komiya T., Komori H., Kon S. P., Kondo M., Kong W., Konishi M., Kono K., Koshino M., Kosugi T., Kothapalli B., Kozlowski T., Kraemer B., Kraemer-Guth A., Krappe J., Kraus D., Kriatselis C., Krieger C., Krish P., Kruger B., Ku Md Razi K. R., Kuan Y., Kubota S., Kuhn S., Kumar P., Kume S., Kummer I., Kumuji R., Kupper A., Kuramae T., Kurian L., Kuribayashi C., Kurien R., Kuroda E., Kurose T., Kutschat A., Kuwabara N., Kuwata H., La Manna G., Lacey M., Lafferty K., LaFleur P., Lai V., Laity E., Lambert A., Landray M. J., Langlois M., Latif F., Latore E., Laundy E., Laurienti D., Lawson A., Lay M., Leal I., Lee A. K., Lee J., Lee K. Q., Lee R., Lee S. A., Lee Y. Y., Lee-Barkey Y., Leonard N., Leoncini G., Leong C. M., Lerario S., Leslie A., Levin A., Lewington A., Li J., Li N., Li X., Li Y., Liberti L., Liberti M. E., Liew A., Liew Y. F., Lilavivat U., Lim S. K., Lim Y. S., Limon E., Lin H., Lioudaki E., Liu H., Liu J., Liu L., Liu Q., Liu W. J., Liu X., Liu Z., Loader D., Lochhead H., Loh C. L., Lorimer A., Loudermilk L., Loutan J., Low C. K., Low C. L., Low Y. M., Lozon Z., Lu Y., Lucci D., Ludwig U., Luker N., Lund D., Lustig R., Lyle S., Macdonald C., MacDougall I., Machicado R., MacLean D., Macleod P., Madera A., Madore F., Maeda K., Maegawa H., Maeno S., Mafham M., Magee J., Maggioni A. P., Mah D. Y., Mahabadi V., Maiguma M., Makita Y., Makos G., Manco L., Mangiacapra R., Manley J., Mann P., Mano S., Marcotte G., Maris J., Mark P., Markau S., Markovic M., Marshall C., Martin M., Martinez C., Martinez S., Martins G., Maruyama K., Maruyama S., Marx K., Maselli A., Masengu A., Maskill A., Masumoto S., Masutani K., Matsumoto M., Matsunaga T., Matsuoka N., Matsushita M., Matthews M., Matthias S., Matvienko E., Maurer M., Maxwell P., Mayne K. J., Mazlan N., Mazlan S. A., Mbuyisa A., McCafferty K., McCarroll F., McCarthy T., McClary-Wright C., McCray K., McDermott P., McDonald C., McDougall R., McHaffie E., McIntosh K., McKinley T., McLaughlin S., McLean N., McNeil L., Measor A., Meek J., Mehta A., Mehta R., Melandri M., Mene P., Meng T., Menne J., Merritt K., Merscher S., Meshykhi C., Messa P., Messinger L., Miftari N., Miller R., Miller Y., Miller-Hodges E., Minatoguchi M., Miners M., Minutolo R., Mita T., Miura Y., Miyaji M., Miyamoto S., Miyatsuka T., Miyazaki M., Miyazawa I., Mizumachi R., Mizuno M., Moffat S., Mohamad Nor F. S., Mohamad Zaini S. N., Mohamed Affandi F. A., Mohandas C., Mohd R., Mohd Fauzi N. A., Mohd Sharif N. H., Mohd Yusoff Y., Moist L., Moncada A., Montasser M., Moon A., Moran C., Morgan N., Moriarty J., Morig G., Morinaga H., Morino K., Morisaki T., Morishita Y., Morlok S., Morris A., Morris F., Mostafa S., Mostefai Y., Motegi M., Motherwell N., Motta D., Mottl A., Moys R., Mozaffari S., Muir J., Mulhern J., Mulligan S., Munakata Y., Murakami C., Murakoshi M., Murawska A., Murphy K., Murphy L., Murray S., Murtagh H., Musa M. A., Mushahar L., Mustafa R., Mustafar R., Muto M., Nadar E., Nagano R., Nagasawa T., Nagashima E., Nagasu H., Nagelberg S., Nair H., Nakagawa Y., Nakahara M., Nakamura J., Nakamura R., Nakamura T., Nakaoka M., Nakashima E., Nakata J., Nakata M., Nakatani S., Nakatsuka A., Nakayama Y., Nakhoul G., Nangaku M., Naverrete G., Navivala A., Nazeer I., Negrea L., Nethaji C., Newman E., Ng S. Y. A., Ng T. J., Ngu L. L. S., Nimbkar T., Nishi H., Nishi M., Nishi S., Nishida Y., Nishiyama A., Niu J., Niu P., Nobili G., Nohara N., Nojima I., Nolan J., Nosseir H., Nozawa M., Nunn M., Nunokawa S., Oda M., Oe M., Oe Y., Ogane K., Ogawa W., Ogihara T., Oguchi G., Ohsugi M., Oishi K., Okada Y., Okajyo J., Okamoto S., Okamura K., Olufuwa O., Oluyombo R., Omata A., Omori Y., Ong L. M., Ong Y. C., Onyema J., Oomatia A., Oommen A., Oremus R., Orimo Y., Ortalda V., Osaki Y., Osawa Y., Osmond Foster J., O'Sullivan A., Otani T., Othman N., Otomo S., O'Toole J., Owen L., Ozawa T., Padiyar A., Page N., Pajak S., Paliege A., Pandey A., Pandey R., Pariani H., Park J., Parrigon M., Passauer J., Patecki M., Patel M., Patel R., Patel T., Patel Z., Paul R., Paulsen L., Pavone L., Peixoto A., Peji J., Peng B. C., Peng K., Pennino L., Pereira E., Perez E., Pergola P., Pesce F., Pessolano G., Petchey W., Petr E. J., Pfab T., Phelan P., Phillips R., Phillips T., Phipps M., Piccinni G., Pickett T., Pickworth S., Piemontese M., Pinto D., Piper J., Plummer-Morgan J., Poehler D., Polese L., Poma V., Pontremoli R., Postal A., Potz C., Power A., Pradhan N., Pradhan R., Preiss D., Preiss E., Preston K., Prib N., Price L., Provenzano C., Pugay C., Pulido R., Putz F., Qiao Y., Quartagno R., Quashie-Akponeware M., Rabara R., Rabasa-Lhoret R., Radhakrishnan D., Radley M., Raff R., Raguwaran S., Rahbari-Oskoui F., Rahman M., Rahmat K., Ramadoss S., Ramanaidu S., Ramasamy S., Ramli R., Ramli S., Ramsey T., Rankin A., Rashidi A., Raymond L., Razali W. A. F. A., Read K., Reiner H., Reisler A., Reith C., Renner J., Rettenmaier B., Richmond L., Rijos D., Rivera R., Rivers V., Robinson H., Rocco M., Rodriguez-Bachiller I., Rodriquez R., Roesch C., Roesch J., Rogers J., Rohnstock M., Rolfsmeier S., Roman M., Romo A., Rosati A., Rosenberg S., Ross T., Rossello X., Roura M., Roussel M., Rovner S., Roy S., Rucker S., Rump L., Ruocco M., Ruse S., Russo F., Russo M., Ryder M., Sabarai A., Sacca C., Sachson R., Sadler E., Safiee N. S., Sahani M., Saillant A., Saini J., Saito C., Saito S., Sakaguchi K., Sakai M., Salim H., Salviani C., Sammons E., Sampson A., Samson F., Sandercock P., Sanguila S., Santorelli G., Santoro D., Sarabu N., Saram T., Sardell R., Sasajima H., Sasaki T., Satko S., Sato A., Sato D., Sato H., Sato J., Sato T., Sato Y., Satoh M., Sawada K., Schanz M., Scheidemantel F., Schemmelmann M., Schettler E., Schettler V., Schlieper G. R., Schmidt C., Schmidt G., Schmidt U., Schmidt-Gurtler H., Schmude M., Schneider A., Schneider I., Schneider-Danwitz C., Schomig M., Schramm T., Schreiber A., Schricker S., Schroppel B., Schulte-Kemna L., Schulz E., Schumacher B., Schuster A., Schwab A., Scolari F., Scott A., Seeger W., Segal M., Seifert L., Seifert M., Sekiya M., Sellars R., Seman M. R., Shah S., Shainberg L., Shanmuganathan M., Shao F., Sharma K., Sharpe C., Sheikh-Ali M., Sheldon J., Shenton C., Shepherd A., Shepperd M., Sheridan R., Sheriff Z., Shibata Y., Shigehara T., Shikata K., Shimamura K., Shimano H., Shimizu Y., Shimoda H., Shin K., Shivashankar G., Shojima N., Silva R., Sim C. S. B., Simmons K., Sinha S., Sitter T., Sivanandam S., Skipper M., Sloan K., Sloan L., Smith R., Smyth J., Sobande T., Sobata M., Somalanka S., Song X., Sonntag F., Sood B., Sor S. Y., Soufer J., Sparks H., Spatoliatore G., Spinola T., Squyres S., Srivastava A., Stanfield J., Staplin N., Staylor K., Steele A., Steen O., Steffl D., Stegbauer J., Stellbrink C., Stellbrink E., Stevens W., Stevenson A., Stewart-Ray V., Stickley J., Stoffler D., Stratmann B., Streitenberger S., Strutz F., Stubbs J., Stumpf J., Suazo N., Suchinda P., Suckling R., Sudin A., Sugamori K., Sugawara H., Sugawara K., Sugimoto D., Sugiyama H., Sugiyama T., Sullivan M., Sumi M., Suresh N., Sutton D., Suzuki H., Suzuki R., Suzuki Y., Swanson E., Swift P., Syed S., Szerlip H., Taal M., Taddeo M., Tailor C., Tajima K., Takagi M., Takahashi K., Takahashi M., Takahashi T., Takahira E., Takai T., Takaoka M., Takeoka J., Takesada A., Takezawa M., Talbot M., Taliercio J., Talsania T., Tamori Y., Tamura R., Tamura Y., Tan C. H. H., Tan E. Z. Z., Tanabe A., Tanabe K., Tanaka A., Tanaka N., Tang S., Tang Z., Tanigaki K., Tarlac M., Tatsuzawa A., Tay J. F., Tay L. L., Taylor J., Taylor K., Te A., Tenbusch L., Teng K. S., Terakawa A., Terry J., Tham Z. D., Tholl S., Thomas G., Thong K. M., Tietjen D., Timadjer A., Tindall H., Tipper S., Tobin K., Toda N., Tokuyama A., Tolibas M., Tomita A., Tomita T., Tomlinson J., Tonks L., Topf J., Topping S., Torp A., Torres A., Totaro F., Toth P., Toyonaga Y., Tripodi F., Trivedi K., Tropman E., Tschope D., Tse J., Tsuji K., Tsunekawa S., Tsunoda R., Tucky B., Tufail S., Tuffaha A., Turan E., Turner H., Turner J., Turner M., Tuttle K. R., Tye Y. L., Tyler A., Tyler J., Uchi H., Uchida H., Uchida T., Udagawa T., Ueda S., Ueda Y., Ueki K., Ugni S., Ugwu E., Umeno R., Unekawa C., Uozumi K., Urquia K., Valleteau A., Valletta C., van Erp R., Vanhoy C., Varad V., Varma R., Varughese A., Vasquez P., Vasseur A., Veelken R., Velagapudi C., Verdel K., Vettoretti S., Vezzoli G., Vielhauer V., Viera R., Vilar E., Villaruel S., Vinall L., Vinathan J., Visnjic M., Voigt E., von-Eynatten M., Vourvou M., Wada J., Wada T., Wada Y., Wakayama K., Wakita Y., Wallendszus K., Walters T., Wan Mohamad W. H., Wang L., Wang W., Wang X., Wang Y., Wanner C., Wanninayake S., Watada H., Watanabe K., Watanabe M., Waterfall H., Watkins D., Watson S., Weaving L., Weber B., Webley Y., Webster A., Webster M., Weetman M., Wei W., Weihprecht H., Weiland L., Weinmann-Menke J., Weinreich T., Wendt R., Weng Y., Whalen M., Whalley G., Wheatley R., Wheeler A., Wheeler J., Whelton P., White K., Whitmore B., Whittaker S., Wiebel J., Wiley J., Wilkinson L., Willett M., Williams A., Williams E., Williams K., Williams T., Wilson A., Wilson P., Wincott L., Wines E., Winkelmann B., Winkler M., Winter-Goodwin B., Witczak J., Wittes J., Wittmann M., Wolf G., Wolf L., Wolfling R., Wong C., Wong E., Wong H. S., Wong L. W., Wong Y. H., Wonnacott A., Wood A., Wood L., Woodhouse H., Wooding N., Woodman A., Wren K., Wu J., Wu P., Xia S., Xiao H., Xiao X., Xie Y., Xu C., Xu Y., Xue H., Yahaya H., Yalamanchili H., Yamada A., Yamada N., Yamagata K., Yamaguchi M., Yamaji Y., Yamamoto A., Yamamoto S., Yamamoto T., Yamanaka A., Yamano T., Yamanouchi Y., Yamasaki N., Yamasaki Y., Yamashita C., Yamauchi T., Yan Q., Yanagisawa E., Yang F., Yang L., Yano S., Yao S., Yao Y., Yarlagadda S., Yasuda Y., Yiu V., Yokoyama T., Yoshida S., Yoshidome E., Yoshikawa H., Young A., Young T., Yousif V., Yu H., Yu Y., Yuasa K., Yusof N., Zalunardo N., Zander B., Zani R., Zappulo F., Zayed M., Zemann B., Zettergren P., Zhang H., Zhang L., Zhang N., Zhang X., Zhao J., Zhao L., Zhao S., Zhao Z., Zhong H., Zhou N., Zhou S., Zhu D., Zhu L., Zhu S., Zietz M., Zippo M., Zirino F., Zulkipli F. H., Judge P. K., Emberson J. R., Roddick A. J., Liu Z. H., Hooi L. S., Steubl D., Massey D.

المساهمون: Abat S., Abd Rahman R., Abdul Cader R., Abdul Hafidz M.I., Abdul Wahab M.Z., Abdullah N.K., Abdul-Samad T., Abe M., Abraham N., Acheampong S., Achiri P., Acosta J.A., Adeleke A., Adell V., Adewuyi-Dalton R., Adnan N., Africano A., Agharazii M., Aguilar F., Aguilera A., Ahmad M., Ahmad M.K., Ahmad N.A., Ahmad N.H., Ahmad N.I., Ahmad Miswan N., Ahmad Rosdi H., Ahmed I., Ahmed S., Aiello J., Aitken A., AitSadi R., Aker S., Akimoto S., Akinfolarin A., Akram S., Alberici F., Albert C., Aldrich L., Alegata M., Alexander L., Alfaress S., Alhadj Ali M., Ali A., Alicic R., Aliu A., Almaraz R., Almasarwah R., Almeida J., Aloisi A., Al-Rabadi L., Alscher D., Alvarez P., Al-Zeer B., Amat M., Ambrose C., Ammar H., An Y., Andriaccio L., Ansu K., Apostolidi A., Arai N., Araki H., Araki S., Arbi A., Arechiga O., Armstrong S., Arnold T., Aronoff S., Arriaga W., Arroyo J., Arteaga D., Asahara S., Asai A., Asai N., Asano S., Asawa M., Asmee M.F., Aucella F., Augustin M., Avery A., Awad A., Awang I.Y., Awazawa M., Axler A., Ayub W., Azhari Z., Baccaro R., Badin C., Bagwell B., Bahlmann-Kroll E., Bahtar A.Z., Baigent C., Bains D., Bajaj H., Baker R., Baldini E., Banas B., Banerjee D., Banno S.

الوصف: Background: The EMPA KIDNEY trial showed that empagliflozin reduced the risk of the primary composite outcome of kidney disease progression or cardiovascular death in patients with chronic kidney disease mainly through slowing progression. We aimed to assess how effects of empagliflozin might differ by primary kidney disease across its broad population. Methods: EMPA-KIDNEY, a randomised, controlled, phase 3 trial, was conducted at 241 centres in eight countries (Canada, China, Germany, Italy, Japan, Malaysia, the UK, and the USA). Patients were eligible if their estimated glomerular filtration rate (eGFR) was 20 to less than 45 mL/min per 1·73 m2, or 45 to less than 90 mL/min per 1·73 m2 with a urinary albumin-to-creatinine ratio (uACR) of 200 mg/g or higher at screening. They were randomly assigned (1:1) to 10 mg oral empagliflozin once daily or matching placebo. Effects on kidney disease progression (defined as a sustained ≥40% eGFR decline from randomisation, end-stage kidney disease, a sustained eGFR below 10 mL/min per 1·73 m2, or death from kidney failure) were assessed using prespecified Cox models, and eGFR slope analyses used shared parameter models. Subgroup comparisons were performed by including relevant interaction terms in models. EMPA-KIDNEY is registered with ClinicalTrials.gov, NCT03594110. Findings: Between May 15, 2019, and April 16, 2021, 6609 participants were randomly assigned and followed up for a median of 2·0 years (IQR 1·5–2·4). Prespecified subgroupings by primary kidney disease included 2057 (31·1%) participants with diabetic kidney disease, 1669 (25·3%) with glomerular disease, 1445 (21·9%) with hypertensive or renovascular disease, and 1438 (21·8%) with other or unknown causes. Kidney disease progression occurred in 384 (11·6%) of 3304 patients in the empagliflozin group and 504 (15·2%) of 3305 patients in the placebo group (hazard ratio 0·71 [95% CI 0·62–0·81]), with no evidence that the relative effect size varied significantly by primary kidney disease (pheterogeneity=0·62). The ...

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38061372; info:eu-repo/semantics/altIdentifier/wos/WOS:001148079800001; volume:12; issue:1; firstpage:51; lastpage:60; numberofpages:10; journal:THE LANCET DIABETES & ENDOCRINOLOGY; https://hdl.handle.net/11585/963286Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85179107702; https://www.thelancet.com/journals/landia/article/PIIS2213-8587Test(23)00322-4/fulltext

الإتاحة: https://doi.org/10.1016/S2213-8587Test(23)00322-4
https://hdl.handle.net/11585/963286Test
https://www.thelancet.com/journals/landia/article/PIIS2213-8587Test(23)00322-4/fulltext

المؤلفون: Byrne, JF, Healy, C, Focking, M, Susai, SR, Mongan, D, Wynne, K, Kodosaki, E, Heurich, M, de Haan, L, Hickie, IB, Smesny, S, Thompson, A, Markulev, C, Young, AR, Schafer, MR, Riecher-Rossler, A, Mossaheb, N, Berger, G, Schlogelhofer, M, Nordentoft, M, Chen, EYH, Verma, S, Nieman, DH, Woods, SW, Cornblatt, BA, Stone, WS, Mathalon, DH, Bearden, CE, Cadenhead, KS, Addington, J, Walker, EF, Cannon, TD, Cannon, M, McGorry, P, Amminger, P, Cagney, G, Nelson, B, Jeffries, C, Perkins, D, Cotter, DR

الوصف: Psychosis risk prediction is one of the leading challenges in psychiatry. Previous investigations have suggested that plasma proteomic data may be useful in accurately predicting transition to psychosis in individuals at clinical high risk (CHR). We hypothesized that an a priori-specified proteomic prediction model would have strong predictive accuracy for psychosis risk and aimed to replicate longitudinal associations between plasma proteins and transition to psychosis. This study used plasma samples from participants in 3 CHR cohorts: the North American Prodrome Longitudinal Studies 2 and 3, and the NEURAPRO randomized control trial (total n = 754). Plasma proteomic data were quantified using mass spectrometry. The primary outcome was transition to psychosis over the study follow-up period. Logistic regression models were internally validated, and optimism-corrected performance metrics derived with a bootstrap procedure. In the overall sample of CHR participants (age: 18.5, SD: 3.9; 51.9% male), 20.4% (n = 154) developed psychosis within 4.4 years. The a priori-specified model showed poor risk-prediction accuracy for the development of psychosis (C-statistic: 0.51 [95% CI: 0.50, 0.59], calibration slope: 0.45). At a group level, Complement C8B, C4B, C5, and leucine-rich α-2 glycoprotein 1 (LRG1) were associated with transition to psychosis but did not surpass correction for multiple comparisons. This study did not confirm the findings from a previous proteomic prediction model of transition from CHR to psychosis. Certain complement proteins may be weakly associated with transition at a group level. Previous findings, derived from small samples, should be interpreted with caution.

العلاقة: NHMRC/566529; pii: 7578384; Byrne, J. F., Healy, C., Focking, M., Susai, S. R., Mongan, D., Wynne, K., Kodosaki, E., Heurich, M., de Haan, L., Hickie, I. B., Smesny, S., Thompson, A., Markulev, C., Young, A. R., Schafer, M. R., Riecher-Rossler, A., Mossaheb, N., Berger, G., Schlogelhofer, M. ,. Cotter, D. R. (2024). Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study. SCHIZOPHRENIA BULLETIN, 50 (3), https://doi.org/10.1093/schbul/sbad184Test.; http://hdl.handle.net/11343/344448Test

الإتاحة: https://doi.org/10.1093/schbul/sbad184Test
http://hdl.handle.net/11343/344448Test

المؤلفون: Dooley, N. (Niamh), Kennelly, B. (Brendan), Arseneault, L. (Louise), Zammit, S. (Stanley), Whelan, R. (Rob), Mosley, O. (Olivia), Cotter, D. (Delia), Clarke, M. (Mary), Cotter, D. R. (David R.), Kelleher, I. (Ian), McGorry, P. (Pat), Healy, C. (Colm), Cannon, M. (Mary)

الوصف: Importance: Understanding which children in the general population are at greatest risk of poor functional outcomes could improve early screening and intervention strategies. Objective: To investigate the odds of poor outcomes in emerging adulthood (ages 17 to 20 years) for children with different mental health trajectories at ages 9 to 13 years. Design, Setting, and Participants: Growing Up in Ireland is a longitudinal, nationally representative population-based cohort study. Data collection began in August 2007 and was repeated most recently in September 2018. All results were weighted to account for sampling bias and attrition and were adjusted for socioeconomic factors. Data analysis took place from October 2022 to April 2023. Exposure: Four latent classes captured variation in mental health in children aged 9 and 13 years, based on the parent-completed Strengths and Difficulties Questionnaire. Classes included no psychopathology, internalizing, externalizing, and high (comorbid) psychopathology. Those who remained in the same class from ages 9 to 13 years were included. Main Outcomes and Measures: Poor functional outcomes in emerging adulthood were measured at approximate ages 17 years (range, 16 to 18 years) and 20 years (range, 19 to 21 years). Outcomes included poor mental health, poor physical health, social isolation, heavy substance use, frequent health service use, poor subjective well-being, and adverse educational/economic outcomes. Results: Of 5141 included participants, 2618 (50.9%) were male. A total of 3726 (72.5%) were classed as having no childhood psychopathology, 1025 (19.9%) as having persistent externalizing psychopathology, 243 (4.7%) as having persistent internalizing psychopathology, and 147 (2.9%) as having persistent high psychopathology. Having any childhood psychopathology was associated with poorer functional outcomes in emerging adulthood. The internalizing group had elevated odds of most outcomes except for heavy substance use (range of odds ratios [ORs]: 1.38 [95% CI, ...

وصف الملف: application/pdf

الإتاحة: http://urn.fi/urn:nbn:fi-fe20231013139995Test

المؤلفون: Ffrench, C, Finn, D, Velligna, A, Ivory, J, Healy, C, Butler, K, Sezgin, D, Carr, P, Probst, S, McLoughlin, A, Arshad, S, McIntosh, C, Gethin, G

مصطلحات موضوعية: Pain, Clinical sciences, Neurosciences, Pharmacology and pharmaceutical sciences

الوصف: Chronic wounds adversely affect quality of life. Pain is associated with chronic wounds, and its impact can vary according to wound aetiology, condition, and patient factors. This systematic review examined the effectiveness of topical interventions in the management chronic wound–related pain guided by PRISMA recommendations of randomised controlled trials (RCTs) where pain reduction is the primary outcome. Inclusion criteria were adults (older than 18 years) with chronic venous, arterial, diabetic, or pressure ulcers where pain has been managed through topical administration of pharmacological/nonpharmacological agents. Searches were conducted in Ovid Embase, Ovid MEDLINE, EBSCOhost, CINAHL, CENTRAL, PubMed, Web of Science, and Scopus. Studies were screened for eligibility; risk of bias and data were extracted by 2 independent assessors. Searches retrieved 10,327 titles and abstracts (7760 after deduplication). Nine full texts (1323 participants) examining ibuprofen (n = 4), morphine (n = 2), BWD + PHMB [polihexanide-containing biocellulose wound dressing] (n = 1), and EMLA (n = 2) were included. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. Meta-analysis was not possible, but initial exploration suggests improved outcomes (reduced pain) for ibuprofen when compared with controls. Two studies involving morphine showed conflicting findings. Included studies often had small samples, and considering confounding factors (eg, comorbidities), the results should be interpreted with caution. Review of included studies suggests that topical interventions may provide pain relief in individuals with chronic wounds. Further adequately powered RCTs are recommended to assess the efficacy of topical interventions for the management of chronic wound–related pain. ; Full Text

العلاقة: Pain Reports; Ffrench, C; Finn, D; Velligna, A; Ivory, J; Healy, C; Butler, K; Sezgin, D; Carr, P; Probst, S; McLoughlin, A; Arshad, S; McIntosh, C; Gethin, G, Systematic review of topical interventions for the management of pain in chronic wounds, Pain Reports, 2023, 8 (5), pp. e1073; http://hdl.handle.net/10072/427188Test

الإتاحة: https://doi.org/10.1097/PR9.0000000000001073Test
http://hdl.handle.net/10072/427188Test

المؤلفون: Orbea, Marisa, Panjabi, Anurag, Lopez, Michelle, Cunningham, Rachel, Boom, Julie A, Healy, C Mary, Bocchini, Claire

المصدر: Open Forum Infectious Diseases ; volume 10, issue Supplement_2 ; ISSN 2328-8957

مصطلحات موضوعية: Infectious Diseases, Oncology

الوصف: Background Vaccine hesitancy (VH) is adversely affecting the public health response to the COVID-19 pandemic. Similarly, influenza vaccine uptake is suboptimal. We monitored trends in VH to influenza, COVID-19, and routine childhood vaccines. Methods A repeated cross-sectional survey in English and Spanish of caregiver influenza and COVID-19 knowledge, attitudes, behaviors, and associated VH among hospitalized children 6 mo-18 yrs at a pediatric hospital. We enrolled over 4 seasons (S); ‘19-20 (S1), ‘20-21 (S2), ‘21-22 (S3), ‘22-23 (S4). In S4, we targeted caregivers of children 6 mo-11 yrs. VH was assessed using the Parent Attitudes about Childhood Vaccines (PACV) survey; PACV score ≥ 50 denoted VH. In S4, a messaging intervention was piloted. Caregivers were randomized to watch 1 of 2 COVID-19 educational videos; half watched a second video featuring a family adversely impacted by COVID-19. All caregivers completed a survey to assess acceptance and efficacy of the video(s) in changing intent to vaccinate their child. Figure 1. Participant flow chart from 2019-2023 Results Across all seasons, ≥ 92% of caregivers approached were enrolled. Most (48%) identified as Hispanic/Latino, 35% as White, and 19% as Black. By parental report, 94% of children in S1, 91% in S2, 91% in S3, and 89% in S4 were up-to-date with routine vaccines. Based on PACV score, 13% were VH in S1, 17% in S2, 19% in S3, and 20% in S4 (p=0.14). During S2-3, fewer caregivers endorsed “flu can be a dangerous infection in children” and “I am scared of my child getting the flu” (p< 0.01). Decreased concern recovered in S4 but did not translate to increased vaccine uptake (Table 1). Caregivers were less scared of their child getting COVID-19 and more scared of the vaccine in S4. Fewer caregivers in S4 were willing to receive the COVID-19 vaccine; 46% in S2, 54% in S3, and 29% in S4 had/planned to vaccinate their child (Table 2). Of 800 caregivers, 74% liked the educational videos and 54% thought they were helpful when considering the ...

الإتاحة: https://doi.org/10.1093/ofid/ofad500.1565Test
https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.1565/53759362/ofad500.1565.pdfTest

المؤلفون: Dooley, N, Healy, C, Cotter, D

المصدر: European Journal of Public Health ; volume 33, issue Supplement_2 ; ISSN 1101-1262 1464-360X

مصطلحات موضوعية: Public Health, Environmental and Occupational Health

الوصف: What does young adulthood look like for individuals who had mental health problems across childhood? Using the Growing Up in Ireland cohort (born in 1998 and studied from ages 9 to 20) we explored the association between mental health problems between ages 9 and 13, and subsequent poor outcomes in the same individuals at ages 17-20. We consider educational/economic outcomes, health service use, poor mental and physical health, social isolation, substance abuse, and subjective wellbeing in young adults. In a previous study that used latent class modelling, we identified four groups which captured mental health in a general population sample of children. Between ages 9 and 13, children could be grouped into: a low symptoms group (∼65%), an ‘externalising’ group with ADHD or conduct symptoms (∼20%), an ‘internalising’ group with depressive, anxiety or peer issues (∼10%), or a group showing many combined mental health symptoms (∼2%). All mental health problem groups had elevated odds across all 7 adverse outcomes in young adulthood. The 5 areas of young adult functioning most related to childhood mental health were: education/economics, subjective wellbeing, mental health, social isolation and substance abuse. Poor educational/economic outcomes were as likely as poor mental health (OR ∼ 2) in individuals with childhood psychopathology. The 3 childhood problem groups showed different risk profiles in young adulthood. For instance, the childhood internalising group had lower odds of substance abuse than all other groups, but had the highest odds of poor physical health by adulthood. Findings point to the need for a wider range of preventative supports for children and adolescents with a history of mental health problems, beyond just mental health support. These include interventions to improve physical health, treat substance abuse, reduce social isolation, and improve adverse educational and economic outcomes.

الإتاحة: https://doi.org/10.1093/eurpub/ckad160.655Test
https://academic.oup.com/eurpub/article-pdf/33/Supplement_2/ckad160.655/52416574/ckad160.655.pdfTest

المؤلفون: Staines, L, Healy, C, Cotter, D, Cannon, M

المصدر: European Journal of Public Health ; volume 33, issue Supplement_2 ; ISSN 1101-1262 1464-360X

مصطلحات موضوعية: Public Health, Environmental and Occupational Health

الوصف: Background and Hypothesis Psychotic experiences (PEs) are associated with increased risk for mental disorders, in particular persistent PEs. PEs therefore might be useful within intervention research. We sought to systematically determine the incidence and persistence of PEs in the general population. Study Design: A double-blind search of databases (Embase, Pubmed PMC, Psychinfo, Medline, and Web of Science) from inception to January 2023 and data extraction, were conducted. Study quality was assessed using the NIH assessment tool. Random effects models were conducted to calculate pooled incidence rate per personyear and proportion of persistent PEs per year. Age and study design were all examined using subgroup analyses. Demographic, risk factors, and outcomes for incidence and persistence of PEs were reported in a narrative synthesis. Results Using a double-blind screening method for abstract (k = 5763) and full text (k = 250) were screened. In total 91 samples from 71 studies were included, of which 39 were included in a meta-analysis (incidence: k = 17, n = 56 089; persistence: k = 22, n = 81 847). Incidence rate was 0.023 per person-year (95% CI [0.0129;0.0322]). That is, for every 100 people, 2 reported first onset PEs in a year. This was highest in adolescence at 5 per 100(13-17 years). The pooled persistence rate for PEs was 31.0% (95% CI [26.65,35.35]) This was highest in adolescence at 35.8%. Cannabis was particularly associated with incidence of PEs, and persistence of PEs were associated with multiple mental disorders. Conclusions Each year incidence of PEs is 2 of every 100 people, and persists each year in 31% of cases, this risk is highest in adolescents.

الإتاحة: https://doi.org/10.1093/eurpub/ckad160.657Test
https://academic.oup.com/eurpub/article-pdf/33/Supplement_2/ckad160.657/52416570/ckad160.657.pdfTest